blog

Summer Doldrums Set In as Latigo (LTGO) and BlossomHill (BLSM) Close Out a Quieter Week for the IPO Market

Written by Eric Friedman | Aug 7, 2026, 8:44:49 PM

The IPO market showed signs of its traditional late-summer slowdown Friday as Latigo Biotherapeutics (LTGO) and BlossomHill Therapeutics (BLSM) made their Nasdaq debuts. Both biotechnology offerings found enough support to avoid significant breaks below their IPO prices by the close, but neither produced the sustained aftermarket momentum that characterized some of the stronger new issues earlier this summer.

Latigo priced 19.2 million shares at $18.00, raising approximately $346 million, and opened at $21.00, a 16.7% premium to its IPO price. The shares initially traded as high as $22.47, but the early strength quickly faded. LTGO ultimately closed at $18.25, down 13.1% from its opening trade and just 1.4% above its IPO price, on approximately 2.59 million shares of volume.

IPO Prophet began the session with neutral sentiment on Latigo at the open, with no bullish sentiment triggered following the initial trade. As the early premium began to erode and the stock moved steadily lower, sentiment shifted to bearish relatively early in the trading session and remained bearish as the shares continued downward toward the $18.00 deal price.

BlossomHill had a considerably more subdued debut. The company priced 9.38 million shares at $16.00, raising approximately $150 million, before opening at $15.75, already 1.6% below its IPO price. The stock traded as low as $15.38 before recovering during the afternoon and eventually closing at $16.00, exactly at its IPO price, on approximately 1.08 million shares of volume.

IPO Prophet's sentiment on BlossomHill was bearish from the open and remained bearish throughout the trading day. Although the late recovery back to the $16.00 IPO price was constructive relative to the session low, the offering never developed the type of sustained demand or price momentum that would have changed the bearish assessment.

Taken together, the two debuts provided a fitting snapshot of an IPO market that appears to have lost some of the momentum it carried earlier in the summer. That is not necessarily surprising. August has historically been one of the quieter periods for equity issuance as investors, bankers and management teams contend with vacations and thinner participation, while many prospective issuers prefer to wait for the more active fall financing window.

The important distinction is between a seasonal slowdown and a deterioration in the underlying IPO market. Friday's trading looked more like the former. Latigo still opened substantially above its IPO price, while BlossomHill was able to recover from an early break and finish at its deal price. At the same time, the inability of either stock to generate meaningful follow-through illustrates a market that has become more selective as summer winds down.

That selectivity could become particularly important over the next several weeks. Rather than forcing transactions into a thinner August market, companies with flexibility can use the remainder of the summer to complete SEC reviews, update financials, conduct investor education and prepare to launch when institutional participation returns more fully.

That traditionally makes Labor Day an important dividing line for the IPO calendar. September and October are typically among the more active windows for new issuance, as companies look to complete transactions before year-end and before the Thanksgiving and December holiday periods begin compressing the calendar.

After a productive stretch of new issuance this summer, some cooling in August was to be expected. The bigger test for the IPO market will therefore come after Labor Day. If the broader equity markets remain supportive and volatility stays contained, the combination of companies waiting in the pipeline and a narrowing year-end execution window could produce a busy September and an active fourth quarter.

For now, Latigo and BlossomHill offered a reminder that the late-summer IPO market may require more patience. The calendar may be slowing down, but the more important question is whether it is simply catching its breath before the fall issuance window begins.